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fi-PROPIOLACTONE (3-hydroxypropionic acid lactone, O.CH2.CH2C: O) is a
highly reactive compound of simple structure which is now available in quantity.
It has manypossible uses as an organic synthetic agent, andhas beenrecommended
for sterilising plasma (Hartmann, LoGrippo and Kelly, 1954) and arterial grafts
(Rains et al., 1956) and as a toxoiding agent inplace offormalin (Orlans and Jones,
1958). It is therefore of importance that ,-propiolactone, besides being a vesi-
cant, is also a mutagenic agent (Smith and Srb, 1951), has been found to cause
sarcomas after injection in arachis oil into rats (Walpole et al., 1954) and gives
rise to papillomas and squamous cell carcinomas when applied in acetone solution
to mouse skin (Roe and Glendenning, 1956). fi-Propiolactone is thus suspect as a
carcinogen to man, and Roe and Salaman (1958) have questioned the advisability
of using it for arterial graft sterilisation.
Apart from such practical considerations, it is of considerable theoretical
interest that relatively simple compounds such as /-propiolactone and various
ethyleneimines should have carcinogenic activity. It is possible that studying
the biological reactivity ofthese substances, which Walpole et al. (1954) suggested
may act as carcinogens per se, could give more useful information about the car-
cinogenic process than has hitherto been obtained from work on the aromatic
hydrocarbon carcinogens.
Dickens and Jones (1961) have now shown that a range of other lactones can
induce sarcomas when repeatedly injected into rats. Structural features of the
active compounds are either a highly strained four-membered ring as in fi-
propiolactone and penicillin G, or a five-membered ring with double bonds in the
2- and/or 4-positions, as in patulin and penicillic acid. A number of these com-
pounds have also antibiotic and growth inhibitory activity, and are inactivated
by cysteine.
Among other reactions of ,8-propiolactone those with biological sulphydryl
groups are of particular interest. Searle (1961) investigated the effects offl-pro-
piolactone on the sulphydryl and disulphide groups ofegg and serum albumins by
polarography of the denatured protein solutions at intervals after adding the
lactone. It was found that fl-propiolactone caused immediate destruction of
polarographically active groups in the albumins, but that these effects were
reversible when the solutions were warmed or allowed to stand at room tempera-
ture.
This could indicate that the main product from the reaction off-propiolactone
with cysteine residues in the protein has a hydrolysable thioester grouping. InCARCINOGENICITY OF f-PROPIOLACTONE
a preliminary report Dickens, Jones and Williamson (1956) also named as a
thioester the product C6H1104NS which they obtained from the reaction between
cysteine and /3-propiolactone in neutral solution, but it has now been identified
(Dickens and Jones, 1961) as the thioether S-2-carboxyethylcysteine, HOOC.
CH2.CH2.S.CH2.CH(NH2)COOH.
The formation of thioester and thioether involve opening of the /,-lactone
ring by fission of different C-O bonds as illustrated in Fig. 1. fi-Propiolactone is
known to undergo both types of reaction with OH-groups, methanol for instance
yielding methyl 3-hydroxypropionate inl the presence of alkali and 3-methoxy-
propionic acid in its absence (Fieser and Fieser, 1956). One would, perhaps,
expect an alkylation process with thioether formation to have more relevance
to carcinogenesis than the formation of a thioester which could readily hydrolyse.
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FIa. 1-Reaction off-propiolactone (I) with cysteine derivative (II)by fissionat (a) to yield
a thioether (III) or at (b) to yield a thioester (IV) The latter would be expected to
hydrolyse to give (II) again and 3-hydroxypropionic acid (V) Reaction (a) is known to
occur with free cysteine. Reaction (b) it is suggested, may occur when cysteine is in
protein combination.
In some preliminary small-scale experiments the reaction between f-pro-
piolactone and cysteine was followed by paper chromatography in two solvents
(aqueous phenol-NH3 and aqueous butanol-pyridine, 1:1:1). The reaction
mixtures contained a product believed to be S-2-carboxyethylcysteine since it
had the sameRt value as an authentic specimen (L. Light & Co.) in each solvent.
both with and without prior oxidation of reaction mixture and marker by hydro-
gen peroxide. This result is as expected in view of Dickens and Jones' (1961)
isolation of S-2-carboxyethylcysteine from the reaction at pH 7.
In one experiment, however, it was noticed that the nitroprusside reaction
for-SH, which had become negative on adding the lactone, became positive
again when the solution was allowed to stand. This suggested that under some
conditions cysteine could also yield the thioester on treatment with fs-propio-
lactone. To investigate this possibility the reaction between the compounds has
been carried out in controlled neutral, mildly alkaline and mildly acid conditions,
the course of the reaction being followed polarographically as in the albumin
experiments already reported (Searle, 1961). In view of the destruction of
protein-bound cystine, as well as cysteine, which is thought to have occurred in
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albumin experiments, the action of ,8-propiolactone on free cystine has been
similarly investigated.
If the carcinogenicity of ,-propiolactone is in fact associated with alkylation
by the 2-carboxyethyl group, it seemed possible that fi-(or 3-)bromopropionic
acid, which reacts with cysteine at pH 6-7 to give S-2-carboxyethylcysteine
(Schoberl and Wagner, 1956), might also show some carcinogenic activity. It
has accordingly been tested on mouse skin in experiments reported below. Tests
thought desirable to confirm the carcinogenicity of ,8-propiolactone on a larger
number of mice than had previously been used have also been carried out.
EXPERIMENTAL
Two series of mice have been treated with solutions of f-propiolactone in
acetone (Groups I and II) and one series with 3-bromopropionic acid (Group
III). Details of the materials and animals are recorded below.
Materials
,/-Propiolactone (Kodak Ltd. or L. Light & Co.) was purified before use by
fractional distillation under reduced pressure. The acetone used for Group I
was an ordinary grade, purified by fractional distillation only. For Group II
"Analar" acetone was boiled under reflux with solid potassium permanganate
until no further decolorisation occurred. The solution was filtered, distilled,
dried with anhydrous potassium carbonate, filtered again and fractionally dis-
tilled with precautions to exclude moisture (Vogel, 1956). Solutions of ,8-
propiolactone were made up 2.5 per cent w/v every 2-3 weeks.
3-Bromopropionic acid (B.D.H.) was applied in a 2.5 per cent w/v solution in
the redistilled acetone as used for Group I. All solutions were stored at 4° C.
Animal experiments
The backs of inbred stock albino mice, as normally used inthis departmentfor
carcinogenicity tests, were shaved before commencing treatment and at intervals
thereafter as necessary. Hair growth was appreciably slowed during treatment
with ,-propiolactone but not with 3-bromopropionic acid.
Group I.-Twenty-five mice were treated with 0 3 ml. of the fi-propiolactone
solution in redistilled acetone on the back once weekly for 12 weeks, then twice
weekly for a further 29 weeks. The 20 surviving mice were killed 5 weeks later.
The miceyielded onlyone tumour, which was identified 41 weeks after commencing
treatment as a squamous cell carcinoma.
Group II.-Forty-five mice were treated twice weekly for 60 weeks with 0.3
ml. of the solution of redistilled /-propiolactone in the specially purified acetone.
Mice were killed during the experiment as necessitated by the development of
tumours. Sections were stained (Ehrlich's haematoxylin and eosin; Weigert's
iron haematoxylin and van Gieson's stain) for histological examination by Dr.
A. T. Spencer.
Macroscopic papillomas were found in one mouse after only 16 weeks of treat-
ment, and in a further four mice after 20 weeks. Similar tumours appeared on
other mice at various times up to 60 weeks, and generally proceeded to squamous
cell carcinomas. Althogether 20 mice developed well-differentiated squamous
cell carcinomas, showing varying degrees of infiltration of muscle, in the painted
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area of skin. In addition, one mouse developed a squamous cell papilloma, one
a keratoacanthoma, and two mice showed hyperkeratosis and acanthosis of the
skin with changes suggesting early carcinoma. Macroscopic papillomas on five
other mice were not examined histologically owing to post-mortem changes.
In two mice, killed at 36 and 51 weeks, squamous cell carcinomas developed on
the snout while the treated area ofskin remained free of tumours. Other findings
were two mice with unidentified tumours on the eyelid, one with a spindle cell
sarcoma in the painted area of skin, and one mouse with leukaemia. The re-
maining 11 mice died tumour-free or were killed because of poor condition after
24 to 57 weeks of treatment.
Group III.-Twenty-five mice were treated with the 3-bromopropionic acid
solution once weeklyfor 6 weeks, then twice weekly for 29 weeks. Four mice died
during this period, but no evidence of tumour production had been observed
when the experiment was terminated 5 weeks later. Since the bromopropionic
acid in these experiments was applied in the distilled and not in the specially
purified acetone, a check has since been made which has shown that no detectable
decomposition, with loss of bromide ion, occurred in this solvent after eleven
weeks at room temperature.
Further animal tests
In view of the remarkable resistance ofguinea-pigs to most carcinogens of the
polycyclic hydrocarbon type, it was thought desirable to see if they would be
equally resistant to one of the newer types of carcinogen. ,-Propiolactone is
therefore being applied twice weekly to shaved guinea-pig skin at concentrations
of 2.5 and 5.0 per cent in the purified acetone as used in the mouse experiment
(Group II).
One animal, which is white but not a true albino, showed a number of dark
patches on the skin after only 16 weeks of treatment with the 5 per cent solution.
One patch was removed and identified by Dr. D. J. Parish as a junctional
melanoma. This early result is thought to be connected with skin damage which
the animal received earlier in the course of fighting. Evidence of tumour pro-
duction has not been seen on other guinea-pigs which have been treated for 37
weeks.
Action offi,-propiolactone on cysteine and cystine
The course of these reactions was conveniently followed using a "Cambridge"
Heyrovsky-pattern polarograph with photographic recording as in the albumin
experiments already reported (Searle, 1961). For polarography the test solution
(1-0 ml.) was added to the ammoniacal cobaltous buffer (10.0 ml.) to which was
also added 0.25 ml. of 0-25 per cent gelatin solution. The gelatin suppressed the
maximum at the Co++-Co reduction but not the catalytic cysteine maximum,
the height of which was measured from the level cobalt diffusion current to give a
measure of the amount of unchanged cyst(e)ine in solution.
Cysteine reaction
To 100 mg. of cysteine hydrochloride dissolved in 10 ml. of water and just
neutralised to bromothymol blue (pH range 6-0-7.6) was added 0-10 ml. of fi-
propiolactone (0-115 mg., 2.5 mol. proportions). 05 N NaOH was added at
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frequent intervals to counteract the acidity produced by hydrolysis ofthe lactone.
After 7.5, 15, 30 and 60 minutes aliquots of solution were removed, diluted 100-
fold with water, and polarographed in the cobaltous buffer solution from -0.9
to -2.1 v at a galvanometer sensitivity of 1/200.
For the reactions in weak acid and alkali bromothymol blue was replaced by
bromocresol green (pH range 3.6-5.2) andphenolphthalein (8.3-10.0) respectively.
In neutral solution, a trace of cysteine was just detectable 30 minutes after
adding the lactone but not after 60 minutes. In mildly alkaline solution all
cysteine had disappeared by 7.5 minutes. In the acid range reaction occurred
but was very slow, the height of the catalytic cysteine maximum being reduced
by only 18 per cent after 30 minutes.
In each experiment the solution was finally made just alkaline to phenol-
phthalein and warmed to 60°, when some further reaction occurred in the acidic
experiment. In no experiment was there any recovery of the catalytic wave,
and there is therefore no evidence for formation of thioester in addition to S-2-
carboxyethylcysteine.
Cystine reaction
Due to its insolubility cystine solutions containing only 0.76 mg. in 10 ml.
were employed, but 0-10 ml. of,-propiolactone were added as before, i.e. a much
greater excess. The solutions were added without dilution to the cobaltous
buffer, and polarographed at a sensitivity of 1/500.
An unexpected finding was an increase in the height of the catalytic maximum
on addition of/-propiolactone. In the experiment in neutral solution the maxi-
mum rose from 19.5 scale units at -1.85 v to 24-5 units at -1.94 v after 7.5
minutes, and then rose more slowly to become an inflection at 40 units at -2.1
v after 60 minutes. A slight reduction in height occurred on warming to 60° in
alkaline solution but the original maximum was not recovered. The changes
observed in the mild alkali were almost identical with those in neutral solution.
In mild acid, however, the cystine appeared completely unaffected by f,-pro-
piolactone.
Some polarograms obtained in the reactions of fl-propiolactone with cystine
and cysteine in neutral solution are illustrated in Fig. 2.
DISCUSSION
In the only previous report on the carcinogenicity of f-propiolactone for
mouse skin (Roe and Glendenning, 1956) papillomas began to appear on 5 out of
9 surviving mice after 27 weeks of weekly application of the lactone (2.5 per cent
in "Analar" acetone). After 40 weeks, tumours on two of these mice became
malignant and on two others were regarded as probably malignant. Tumours
were obtained earlier in experiments when treatment for the first 5 weeks was
with a 5 or 10 per cent fl-propiolactone solution, which gave rise to ulceration
and scabbing, and scarring appeared to have a tumour-promoting affect.
Our first series of mice treated with f8-propiolactone only yielded one tumour.
We attributed this result to the decomposition of a considerable proportion of
the lactone by water still present in the acetone after fractional distillation.
"Analar" acetone, which was used by Roe and Glendenning, is now stated to
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contain a maximum of 0.7 per cent ofwater, which is however sufficient to hydro-
lyse 2*8 per cent by weight of added f8-propiolactone. When purifying this
solvent we found it to reduce considerable amounts of potassium permanganate,
suggesting the presence of alcoholic impurity which could also react with /1-
propiolactone. Destruction of lactone would probably be small, however, if
the solution were freshly prepared before each application.
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FIG. 2.-Superimposed tracings of polarograms obtained in reactions of f,-propiolactone
with cystine (A) and cysteine (B) in neutral solution. Polarograms recorded in Brdi6ka's
cobaltous buffer containing gelatin, using saturated calomel electrode. (I) Before addition
of lactone; (II) 15 minutes and (III) 60 minutes after adding lactone. Galvanometer
sensitivity 1/500 (A) or 1/200 (B). (The first wave at approximately 1.0 v represents the
Co++-Co reduction.)
When for Group II we used ,-propiolactone in permanganate-treated, dried
acetone, applied twice as frequently as in Roe and Glendenning's experiments,
somepapillomas occurredearlier thanfoundbythese authors, but on other animals
papillomas took as long as 60 weeks to appear. Of the 34 mice of which stained
sections were examined 20 had squamous cell carcinomas in the painted area,
and of the original 45 mice only 11 were tumour-free at death. A tendency was
noticed for tumours to occur somewhat earlier in mice with some skin damage,
due to clipping of hair or to fighting, as has been observed with some other
carcinogens.
The carcinogenicity of 8-propiolactone for mouse skin is thus amply confirmed,
though it is of course considerably less than that of the polycyclic hydrocarbon
carcinogens which give a high yield oftumours when applied at less than one tenth
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of the dosage used here on a weight basis, or about one fortieth of the dose when
allowance is made for the much smaller molecular weight of ,-propiolactone.
It would certainly seem advisable for human exposure to /?-propiolactone itself
to be as limited as possible.
Whether or not there is any carcinogenic risk attached to materials which
have been sterilised with /8-propiolactone, however, depends only on its break-
down products since all the lactone is destroyed in the process. Of these the
major compounds would be 3-hydroxypropionic acid arising from hydrolysis
and 3-chloropropionic acid from reaction with chloride ion, particularly in plasma.
Our first experiment appears to indicate that 3-hydroxypropionic acid is
virtually devoid of carcinogenic activity, since in the solution with which these
mice were painted the original lactone must have been largely hydrolysed to this
acid. Dickens and Jones (1961) have also been unable to demonstrate any
carcinogenic activity of hydrolysed 8-propiolactone when tested in rats. While
3-chloropropionic acid has not, so far as is known, been tested for carcinogenic
activity, the bromo-analogue was found inactive in the experiment reported
above (Group III). The only other halogenated fatty acid tested appears to
be iodoacetic acid, which Orr (1938) found to cause no changes not attributable
to the solvent when he applied it to mouse skin as a 2 per cent solution in benzene.
It is possible that biological material treated with /-propiolactone would
contain some S-2-carboxyethylcysteine. This compound was also tested for
carcinogenicity by Dickens and Jones, who found a sarcoma in the only rat to
survive 87 weeks of repeated injections of 0.5 mg. The significance of this result
is difficult to assess at present.
It is difficult to correlate the observed effects of 8-propiolactone on cysteine
and cystine in protein combination with its action on the free amino acids. This
is in part owing to the lack of exact knowledge concerning the origin of the cata-
lytic double wave which is obtained when cyst(e)ine-containing proteins are
polarographed in ammoniacal cobaltous buffer. It is usually assumed that only
the second part of the double wave is directly due to the presence of cysteine
and/or cystine in the protein. If this is so, the results of Searle (1961) indicate
that cystine as well as cysteine in the protein can be attacked by ,8i-propiolactone,
since similar results were obtained with egg albumin and with bovine serum
albumin, only the former of which contains appreciable cysteine in the reduced
form. Moreover, the reaction was reversible, leading to the suggestion that a
thioester was formed which became hydrolysed once more when the excess of
lactone had been destroyed by the solvent.
The experiments with free cysteine, however, gave the results which would be
expected in view of Dickens and Jones' isolation of S-2-carboxyethylcysteine in
high yield, i.e. a complete irreversible destruction of the cysteine catalytic wave
on addition of,-propiolactone. Cystine showed an increase in the catalytic
wave due to some interaction which cannot at present be identified.
Some attempts were made during the present work to detect the formation
of S-2-carboxyethylcysteine in fi-propiolactone-treated albumins by two-dimen-
sional paper chromatography of the desalted acid hydrolysates. This method did
not give a definite result since glutamic acid, present in large amount, moved to
an adjacent position on the paper with the solvent mixtures employed. It was
confirmed that little if any destruction of S-2-carboxyethylcysteine would have
occurred during hydrolysis.
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We have thus no evidence that S-alkylation of cysteine can occur when the
amino acid is in protein combination, or whether the ready S-alkylation of free
cysteine has significance with regard to carcinogenesis.
SUMMARY
1. ,-Propiolactone gave rise to papillomas and squamous cell carcinomas in a
high proportion of mice when applied to the skin in carefully purified acetone.
2. 3-Bromopropionic acid showed no evidence of carcinogenicity for mouse
skin.
3. The rapid reaction of ,-propiolactone with cysteine, followed polaro-
graphically, was accelerated in mild alkali and retarded in mild acid.
4. Some form of interaction with cystine, also accelerated by mild alkali,
was suggested by a rise in the polarographic catalytic maximum in cobaltous
buffer.
5. Unlike the reaction offi-propiolactone with albumin cyst(e)ine groups, the
changes observed with free cystine and cysteine were irreversible.
I am very grateful to Dr. A. T. Spencer for reporting on the tumour sections,
and to Dr. D. L. Woodhouse for helpful discussions. The work was supported
by the Birmingham Branch of the British Empire Cancer Campaign.
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